10 ways Emitrr can help you acquire and retain patients while constantly keeping your schedules full Recorded: June 14, 2022
SponsoredHelp save more lives with this parvovirus innovationOur Canine Parvovirus Monoclonal Antibody offered a 93% real-world survival rate for puppies afflicted with parvovirus.1 Discover the future of parvo treatment today! + Read More
SponsoredStart Treating Canine MMVD Patients at Stage B2Learn about early treatment with pimobendan for canine Stage B2 preclinical MMVD patients. + Learn More
SponsoredCurrent users report reduced stress for parvovirus care1Research shows that our Canine Parvovirus Monoclonal Antibody can help veterinary care teams work with less stress.1 Learn what CPMA can do for your parvo protocol. + Read More